Thursday, July 13, 2017
In a medical milestone decades in the making, a gene-altering leukemia therapy got a unanimous vote of confidence from an F.D.A. panel
A Food and Drug Administration panel opened a new era in medicine on Wednesday, unanimously recommending that the agency approve the first-ever treatment that genetically alters a patient’s own cells to fight leukemia, transforming them into what scientists call “a living drug” that powerfully bolsters the immune system to shut down the disease.
at 7/13/2017 10:00:00 AM